News and Comments

Onyx (ONXX) Was Right All Along

  Monday, July 26, 2010

In October 2009, Onyx (ONXX) paid $276 million up front to acquire the privately held Proteolix to get to its multiple myeloma drug carfilzomib. It promised $535 million in future payments largely contingent on carfilzomib's approval. As usual, investors did not like Onyx paying money, because investors do not like any company to pay money to develop or acquire state-of-the- art products. When somebody hates something he sees everything in it with pessimism. Onyx put its hands on carfilzomib, which looked very promising for multiple myeloma cases resistant to current treatments. The breakthrough multiple myeloma drugs Velcade (bortezomib) and Revlimid (lenolidamide) could not prevent the cancer from recurring and failed to work at all on a large percentage of recurrent cancer.  More...


Recent Postings


Archive


Tags

Ionis (IONS) ACADIA (ACAD) Auspex (ASPX) Sangamo (SGMO) Amgen (AMGN) Vitae Pharmaceuticals (VTAE) HALOZYME (HALO) Adaptimmune (ADAP) PORTOLA (PTLA) Velcade (bortezomib) INNOVIVA (INVA) CompuGen (CGEN) Gilead (GILD) Endometrial Cancer Roche (ROCHE) Anacor (ANAC) Pluristem (PSTI) ARGOS (ARGS) Dynavax (DVAX) Micromet (MITI) SERES THERAPEUTICS (MCRB) Incyte (INCY) GlaxoSmithKline (GSK) JOUNCE THERAPEUTICS (JNCE) Theravance Bio Pharma (TBPH) Exelixis (EXEL) Vertex (VRTX) Biocryst (BCRX) Genentech Human Longevity (HLI) Ziofpharm (ZIOP) JUNO (JUNO) Zerenex Elan (ELN) TOKAI (TKAOI) Rapamune Ridaforolimus C4 Therapeutics Biogen Idec (BIIB) SYNTA (SNTA) Bristol-Myers Squibb (BMY) Advaxis (ADXS) KITE (KITE) Intercept (ICPT) ISIS (ISIS) Herceptin Sanofi-Aventis (SAN) NEKTAR (NKTR)) NANTKWEST (NK) Prolor Biotech (PBTH) ZALTRAP™ KERYX (KERX) Global Cell Therapeutics (GBT) Trastuzumab-DM1 Jazz Pharmaceuticals (JAZZ) REGULUS (RGLS) Benlysta (belimumab) Mirati Therapeutics (MRTX) Cytokinetics (CYTK) IDERA (IDRA) Valeant Pharmaceuticals International (VRX) Telaprevir Intermune (ITMN) Dendreon (DNDN) Ariad (ARIA) Regeneron (REGN) CRISPR Therapeutics (CRSP) Spike Therapeutics (ONCE) Idenix (IDIX) Tysabri MODERNA AstraZeneca (AZN) Intrexon (XON) ImmunoGen (IMGN) Editas (EDIT) galapagos (GLPG) Xoma (XOMA) Sanofi (SNA) PTC Therapeutics (PTCT) Agenus (AGEN Alder Biopharmaceuticals (ALDR) RenenxBio (RGNX) Theravance (THRX) CEMPRA (CEMP) NOVOCURE (NVCR) Aimmune Therapeutics (AIMT) OSI (OSIP) Alnylam (ALNY) AGOS (ARGS) Sequenom (SQNM) Sarepta (SRPT) BIOMARIN (BMRN) Abbott Laboratories (ABT) ABBVIE (ABBV) Agenus (AGEN) Human Genome Sciences (HGSI) SUNESIS PHARMACEUTICALS (SNSS) VANDA (VNDA) Sanofi (SNY) AERIE PHARMACEUTICALS Multiple Myeloma Onyx (ONXX) Ocular Therapeutix (OCUL) Seattle Genetics (SGEN) GUARDIAN HEALTH Inovio (INO) ADVENTRIX (ANX) Galena (GALE) Merck (MRK) Roche (RHHBY) Bellicum (BLCM) Illumina (ILMN) Anadys (ANDS) Revlimid (lenolidamide) Prosensa (RNA) Array Pharmaceuticals (ARRY) ARCA (ABIO)